Clinical Trial: A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread

U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256223) titled 'A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread' on Nov. 20.

Brief Summary: This is an open-label, single-arm, prospective, multicenter clinical study designed to evaluate the efficacy and safety of envafolimab in combination with lenvatinib for the treatment of patients with clear cell renal cell carcinoma (ccRCC) accompanied by liver metastases. The Department of Urology at Fudan University Shanghai Cancer Center serves as the primary research center.

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Clear Cell Renal Cell Cancer (ccRCC) Liver Metastasis

Intervention: ...